These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Methods for delivering and evaluating the efficacy of cognitive enhancement. Harvey PD; Keefe RS Handb Exp Pharmacol; 2015; 228():5-25. PubMed ID: 25977078 [TBL] [Abstract][Full Text] [Related]
6. Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers. Costa V; Lugert S; Jagasia R Handb Exp Pharmacol; 2015; 228():99-155. PubMed ID: 25977081 [TBL] [Abstract][Full Text] [Related]
18. Neural targets in the study and treatment of social cognition in autism spectrum disorder. Vahabzadeh A; Landino SM; Finger BC; Carlezon WA; McDougle CJ Handb Exp Pharmacol; 2015; 228():309-34. PubMed ID: 25977088 [TBL] [Abstract][Full Text] [Related]
19. Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457. Callaghan CK; Hok V; Della-Chiesa A; Virley DJ; Upton N; O'Mara SM Neuropharmacology; 2012 Oct; 63(5):890-7. PubMed ID: 22766392 [TBL] [Abstract][Full Text] [Related]
20. New drug development for cognitive enhancement in mental health: challenges and opportunities. Insel T; Krystal J; Ehlers M Neuropharmacology; 2013 Jan; 64():2-7. PubMed ID: 23145450 [No Abstract] [Full Text] [Related] [Next] [New Search]